These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
6. Preparing for the revolution--pharmacogenomics and the clinical lab. Mehr IJ Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591 [TBL] [Abstract][Full Text] [Related]
7. Global pharmacogenomics: where is the research taking us? Olivier C; Williams-Jones B Glob Public Health; 2014; 9(3):312-24. PubMed ID: 24580118 [TBL] [Abstract][Full Text] [Related]
8. Role of pharmacoproteomics in the development of personalized medicine. Jain KK Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547 [TBL] [Abstract][Full Text] [Related]
9. Novel technology and the development of pharmacogenetics within the pharmaceutical industry. Gibson N; Jawaid A; March R Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553 [TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
15. Drug discovery and development in the age of molecular medicine. Vallance P; Levick M Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574 [TBL] [Abstract][Full Text] [Related]
16. Perlegen sciences, inc. Peacock E; Whiteley P Pharmacogenomics; 2005 Jun; 6(4):439-42. PubMed ID: 16004563 [TBL] [Abstract][Full Text] [Related]
17. Awareness survey of parties involved in pharmacogenomics in Japan. Tamaoki M; Gushima H; Tsutani K Pharmacogenomics; 2007 Mar; 8(3):275-86. PubMed ID: 17324116 [TBL] [Abstract][Full Text] [Related]